Opendata, web and dolomites

PLUTO SIGNED

One-of-a-kind therapy for crossed eyes. Helping families to reduce emotional and financial burden of eye therapy.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLUTO project word cloud

Explore the words cloud of the PLUTO project. It provides you a very rough idea of what is the project "PLUTO" about.

treatment    fulfilled    trials    stationary    attend    least    prototypes    outstanding    comfortable    eye    cerebral    sight    sensors    shorter    first    standard    despite    proposition    primary    proving    motion    shorten    therapy    psychosocial    minimized    stimulation    cheap    virtual    untreated    doctors    train    games    batch    remmedvr    times    perception    competitors    sufficient    world    ambylopathy    cortex    visual    surgery    poland    effectiveness    neuropathic    ophthalmology    eyes    patients    doctor    complete    six    pediatric    days    clinical    scaling    made    considering    reducing       started    significantly    months    vision    visits    price    plan    population    home    time    took    patch    tracking    covered    designed    medicine    commercialization    achievements    environment    optometry    tailor    full    eliminating    income    representative    vr    strabismus    half    business    lazy    therapies    enjoyable    natural    cheaper    crossed    stimulate    create    children    child    remote   

Project "PLUTO" data sheet

The following table provides information about the project.

Coordinator
REMMEDVR SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: DOMANIEWSKA 41/10
city: WARSZAWA
postcode: 02 672
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Total cost 2˙767˙900 €
 EC max contribution 1˙937˙530 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REMMEDVR SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (WARSZAWA) coordinator 1˙937˙530.00

Map

 Project objective

Strabismus (crossed eyes) and ambylopathy (lazy eye) are among the most common eye problems in children, affecting up to 5% of the population. Untreated, they may lead to reduced vision in one/both eyes or even complete loss of sight. Despite the treatment methods offered currently by medicine (surgery, eye patch, stationary vision therapy), the need to of cheap and enjoyable treatment for home use that would significantly shorten therapy time and have sufficient effectiveness has not been fulfilled. At RemmedVR, in collaboration with doctors with outstanding achievements in pediatric ophthalmology from Poland and the EU we took the challenge to create a unique world’s first system designed for remote home use, reducing therapy time from six months to 90 days on average, with minimized doctor visits while eliminating psychosocial impact on the child. RemmedVR’s tracking sensors are also unique among available vision therapies. Advanced motion tracking system makes the perception of virtual reality (VR) environment more natural and comfortable to train visual perception with games designed to stimulate the cerebral cortex for neuropathic stimulation. Considering costs of treatment and shorter therapy duration, RemmedVR is available for at least half the price of standard vision therapy and 4 times cheaper than our competitors. It also allows doctors to attend more patients and increase income. The primary objective of the Phase 2 project is to adopt virtual reality-based technology to optometry needs. Our value proposition is based on objective measurement which can be done only through tailor-made eye tracking and hand tracking sensors. Having a batch of representative prototypes, we have started proving the effectiveness of our system in pre-clinical trials. We further want to test our system in full clinical trials. Other steps covered in this project are related to scaling business and implementation of commercialization plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLUTO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLUTO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More